1. Home
  2. SII vs AVDL Comparison

SII vs AVDL Comparison

Compare SII & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
  • AVDL
  • Stock Information
  • Founded
  • SII 2008
  • AVDL 2015
  • Country
  • SII Canada
  • AVDL Ireland
  • Employees
  • SII N/A
  • AVDL N/A
  • Industry
  • SII Finance: Consumer Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SII Finance
  • AVDL Health Care
  • Exchange
  • SII Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • SII 1.1B
  • AVDL 786.3M
  • IPO Year
  • SII N/A
  • AVDL 1996
  • Fundamental
  • Price
  • SII $43.32
  • AVDL $7.85
  • Analyst Decision
  • SII
  • AVDL Strong Buy
  • Analyst Count
  • SII 0
  • AVDL 6
  • Target Price
  • SII N/A
  • AVDL $20.00
  • AVG Volume (30 Days)
  • SII 72.0K
  • AVDL 1.6M
  • Earning Date
  • SII 02-19-2025
  • AVDL 03-03-2025
  • Dividend Yield
  • SII 2.77%
  • AVDL N/A
  • EPS Growth
  • SII 19.61
  • AVDL N/A
  • EPS
  • SII 1.81
  • AVDL N/A
  • Revenue
  • SII $194,378,000.00
  • AVDL $138,160,000.00
  • Revenue This Year
  • SII $8.22
  • AVDL $515.63
  • Revenue Next Year
  • SII $0.44
  • AVDL $49.32
  • P/E Ratio
  • SII $23.97
  • AVDL N/A
  • Revenue Growth
  • SII 32.38
  • AVDL 1523.50
  • 52 Week Low
  • SII $34.51
  • AVDL $7.39
  • 52 Week High
  • SII $48.00
  • AVDL $19.09
  • Technical
  • Relative Strength Index (RSI)
  • SII 55.02
  • AVDL 30.35
  • Support Level
  • SII $41.57
  • AVDL $7.63
  • Resistance Level
  • SII $43.81
  • AVDL $8.07
  • Average True Range (ATR)
  • SII 1.01
  • AVDL 0.45
  • MACD
  • SII 0.28
  • AVDL -0.10
  • Stochastic Oscillator
  • SII 79.01
  • AVDL 11.14

About SII Sprott Inc.

Sprott Inc is an alternative asset manager operating in Canada. The company has four reportable segments: Exchange Listed Products, which includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the Company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; Corporate segment which provides capital, balance sheet management and enterprise shared services to the Company's subsidiaries.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Share on Social Networks: